U.S. FDA approves Botox (onabotulinumtoxinA) for the treatment of lower limb spasticity in adults

22 January 2016 - Botox is the first and only FDA approved neurotoxin treatment for both upper and lower limb spasticity.

For more details, go to: http://www.allergan.com/news/news/thomson-reuters/u-s-fda-approves-botox-onabotulinumtoxina-for-the

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Medicine , US